Moolec Science (MLEC) Cash from Operations (2022 - 2024)
Moolec Science's (MLEC) quarterly Cash from Operations came in at 2153878.0 in Q4 2024, up 44.83% year-on-year from 1487144.58 in Q1 2024, and down 91.26% quarter-over-quarter from 1126149.0 in Q3 2024.
Moolec Science (MLEC) Cash from Operations (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Cash from Operations across 3 years of filings, most recently posting 2153878.0 for Q4 2024.
- Cash from Operations for Q4 2024 came in at 2153878.0, up 44.83% year-over-year; the trailing twelve-month figure through Dec 2024 was 41925394.0 (up 190.7% YoY), and the FY2025 annual result was 3636413.0, down 90.81% from the prior year.
- Cash from Operations came in at 2153878.0 for Q4 2024 at Moolec Science, down from 1126149.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 47845572.0 in Q2 2024 to a low of 36312138.0 in Q2 2023.
- The 3-year median for Cash from Operations is 1434856.0 (2023), against an average of 494126.33.
- Across the five-year window, Cash from Operations sank 18171.76% in 2023 and jumped 231.76% in 2024, its largest moves.
- Moolec Science's Cash from Operations stood at 592663.0 in 2022, then sank by 558.77% to 3904296.0 in 2023, then soared by 44.83% to 2153878.0 in 2024.
- The last three Cash from Operations figures came in at 2153878.0 (Q4 2024), 1126149.0 (Q3 2024), and 47845572.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.15 Mn |
| Dec 31, 2024 | -2.15 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | 47.85 Mn |
| Jun 30, 2024 | 47.85 Mn |
| Mar 31, 2024 | -2.64 Mn |
| Mar 31, 2024 | -2.64 Mn |
| Dec 31, 2023 | -3.90 Mn |
| Dec 31, 2023 | -3.90 Mn |
| Sep 30, 2023 | -1.74 Mn |
| Sep 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | -36.31 Mn |
| Jun 30, 2023 | -36.31 Mn |
| Mar 31, 2023 | -4.26 Mn |
| Mar 31, 2023 | -4.26 Mn |
| Dec 31, 2022 | -592,663.00 |
| Dec 31, 2022 | -592,663.00 |
| Sep 30, 2022 | 9,648.00 |
| Sep 30, 2022 | 9,648.00 |